Skip to main navigation Skip to search Skip to main content

Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: A phase 1 safety and pharmacokinetics study

  • Giovanni Martinelli
  • , Vivian G. Oehler
  • , Cristina Papayannidis
  • , Rachel Courtney
  • , M. Naveed Shaik
  • , Xiaoxi Zhang
  • , Ashleigh O'Connell
  • , Karen R. McLachlan
  • , Xianxian Zheng
  • , Jerald Radich
  • , Michele Baccarani
  • , Hagop M. Kantarjian
  • , Wendy J. Levin
  • , Jorge E. Cortes
  • , Catriona Jamieson

Research output: Contribution to journal › Article › peer-review

104   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: A phase 1 safety and pharmacokinetics study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry